180 related articles for article (PubMed ID: 11863455)
1. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells.
Quievryn G; Messer J; Zhitkovich A
Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells.
Quievryn G; Peterson E; Messer J; Zhitkovich A
Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927
[TBL] [Abstract][Full Text] [Related]
3. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.
Quievryn G; Messer J; Zhitkovich A
Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765
[TBL] [Abstract][Full Text] [Related]
4. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
[TBL] [Abstract][Full Text] [Related]
5. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Zhitkovich A; Quievryn G; Messer J; Motylevich Z
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121
[TBL] [Abstract][Full Text] [Related]
6. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells.
Morse JL; Luczak MW; Zhitkovich A
Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640
[TBL] [Abstract][Full Text] [Related]
7. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis.
Zhitkovich A; Song Y; Quievryn G; Voitkun V
Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050
[TBL] [Abstract][Full Text] [Related]
8. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate.
Tsou TC; Lai HJ; Yang JL
Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of DNA-protein cross-linking by chromium.
Macfie A; Hagan E; Zhitkovich A
Chem Res Toxicol; 2010 Feb; 23(2):341-7. PubMed ID: 19877617
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI).
Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE
Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900
[TBL] [Abstract][Full Text] [Related]
11. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions.
O'Brien T; Mandel HG; Pritchard DE; Patierno SR
Biochemistry; 2002 Oct; 41(41):12529-37. PubMed ID: 12369844
[TBL] [Abstract][Full Text] [Related]
12. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group.
Zhitkovich A; Voitkun V; Costa M
Biochemistry; 1996 Jun; 35(22):7275-82. PubMed ID: 8679557
[TBL] [Abstract][Full Text] [Related]
13. Chemical mechanisms of DNA damage by carcinogenic chromium(VI).
Krawic C; Zhitkovich A
Adv Pharmacol; 2023; 96():25-46. PubMed ID: 36858775
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol.
Carlisle DL; Pritchard DE; Singh J; Owens BM; Blankenship LJ; Orenstein JM; Patierno SR
Toxicol Sci; 2000 May; 55(1):60-8. PubMed ID: 10788560
[TBL] [Abstract][Full Text] [Related]
15. Reductive metabolism of Cr(VI) by cysteine leads to the formation of binary and ternary Cr--DNA adducts in the absence of oxidative DNA damage.
Zhitkovich A; Shrager S; Messer J
Chem Res Toxicol; 2000 Nov; 13(11):1114-24. PubMed ID: 11087433
[TBL] [Abstract][Full Text] [Related]
16. Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels.
Reynolds M; Armknecht S; Johnston T; Zhitkovich A
Mutagenesis; 2012 Jul; 27(4):437-43. PubMed ID: 22241526
[TBL] [Abstract][Full Text] [Related]
17. Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics.
Luczak MW; Green SE; Zhitkovich A
Environ Health Perspect; 2016 Jan; 124(1):61-6. PubMed ID: 25977998
[TBL] [Abstract][Full Text] [Related]
18. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity.
Marchi S; Lankford E; Dorin B; Drummond E; Thomas SC; Woski SA; Vincent JB
Biol Trace Elem Res; 2023 Oct; 201(10):5053-5066. PubMed ID: 36662348
[TBL] [Abstract][Full Text] [Related]
19. Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53.
Reynolds M; Zhitkovich A
Carcinogenesis; 2007 Jul; 28(7):1613-20. PubMed ID: 17301063
[TBL] [Abstract][Full Text] [Related]
20. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism.
Guttmann D; Poage G; Johnston T; Zhitkovich A
Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]